Shared medical decision-making: A new paradigm for behavioral medicine - 1997 presidential address

被引:29
作者
Kaplan, RM [1 ]
机构
[1] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA
关键词
D O I
10.1007/BF02895027
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Different conceptual models lead to different health care choices, The traditional biomedical model emphasizes identification of pathology (diagnosis) and remediation of these biological deficits (treatment). An alternative approach, known as the outcomes model, focuses attention on the outcomes of health care. Specifically, health care is regarded as effective only if it extends life or if it improves quality of life. Indices that combine life expectancy and life quality can be used to monitor the benefits of health care. According to the traditional model, medical cave is effective if it improves a clinical indicator (i.e. reduces blood pressure, decreases tumor size, etc.). According to the outcomes model, treatments are not advocated unless they improve general outcomes. There are circumstances in which clinical indicators improve but general outcomes remain the same or get worse. Data an the detection and treatment of prostate cancer are used to illustrate how these models might lead to different treatment decisions. According to the traditional model, aggressive screening and treatment of prostate cancer should be advocated because more cases ape detected early and more tumors are removed. According to the outcomes model, net quality-adjusted life may be reduced rather than enhanced with screening. Shared medical decision-making is an outgrowth of the outcomes model. Using these methods, patients and providers integrate the best scientific evidence on treatment efficacy with patient preferences for outcomes. Often shared decision-making leads to reductions to the use of medical procedures.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 65 条
  • [1] *AM CANC SOC, 1997, CANC FACTS FIG 1997
  • [2] [Anonymous], 1996, Quality of Life and Pharmacoeconomics in Clinical Trials
  • [3] [Anonymous], 1998, DARTMOUTH ATLAS HLTH
  • [4] Cancer undefeated
    Bailar, JC
    Gornik, HL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (22) : 1569 - 1574
  • [5] PROSTATE SPECIFIC ANTIGEN DENSITY - A MEANS OF DISTINGUISHING BENIGN PROSTATIC HYPERTROPHY AND PROSTATE-CANCER
    BENSON, MC
    WHANG, IS
    PANTUCK, A
    RING, K
    KAPLAN, SA
    OLSSON, CA
    COONER, WH
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 815 - 816
  • [6] ADVANCES IN DIAGNOSTIC-IMAGING AND OVERESTIMATIONS OF DISEASE PREVALENCE AND THE BENEFITS OF THERAPY
    BLACK, WC
    WELCH, HG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) : 1237 - 1243
  • [7] Screening for disease
    Black, WC
    Welch, HG
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (01) : 3 - 11
  • [8] MONITORING QUALITY OF CARE IN THE MEDICARE PROGRAM - 2 PROPOSED SYSTEMS
    BROOK, RH
    LOHR, KN
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (21): : 3138 - 3141
  • [9] CATALONA WJ, 1995, JAMA-J AM MED ASSOC, V274, P1214
  • [10] Tobacco addiction: Implications for treatment and cancer prevention
    Cinciripini, PM
    Hecht, SS
    Henningfield, JE
    Manley, MW
    Kramer, BS
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24): : 1852 - 1867